miércoles, 30 de mayo de 2018

CF Patients with 2 F508del Mutations to Test Vertex's VX-659 Combo in Phase 3 Trial

CF Patients with 2 F508del Mutations to Test Vertex's VX-659 Combo in Phase 3 Trial

Cystic Fibrosis News Today

Vertex’s VX-659 Triple Combo To Be Tested in Phase 3 Trial in Patients with 2 Copies of F508del Mutation

No hay comentarios:

Publicar un comentario